288 related articles for article (PubMed ID: 12704193)
1. FKBP12 binding to RyR1 modulates excitation-contraction coupling in mouse skeletal myotubes.
Avila G; Lee EH; Perez CF; Allen PD; Dirksen RT
J Biol Chem; 2003 Jun; 278(25):22600-8. PubMed ID: 12704193
[TBL] [Abstract][Full Text] [Related]
2. FKBP12 binding modulates ryanodine receptor channel gating.
Gaburjakova M; Gaburjakova J; Reiken S; Huang F; Marx SO; Rosemblit N; Marks AR
J Biol Chem; 2001 May; 276(20):16931-5. PubMed ID: 11279144
[TBL] [Abstract][Full Text] [Related]
3. Functional effects of central core disease mutations in the cytoplasmic region of the skeletal muscle ryanodine receptor.
Avila G; Dirksen RT
J Gen Physiol; 2001 Sep; 118(3):277-90. PubMed ID: 11524458
[TBL] [Abstract][Full Text] [Related]
4. Reconstitution of local Ca2+ signaling between cardiac L-type Ca2+ channels and ryanodine receptors: insights into regulation by FKBP12.6.
Goonasekera SA; Chen SR; Dirksen RT
Am J Physiol Cell Physiol; 2005 Dec; 289(6):C1476-84. PubMed ID: 16049053
[TBL] [Abstract][Full Text] [Related]
5. The pore region of the skeletal muscle ryanodine receptor is a primary locus for excitation-contraction uncoupling in central core disease.
Avila G; O'Connell KM; Dirksen RT
J Gen Physiol; 2003 Apr; 121(4):277-86. PubMed ID: 12642598
[TBL] [Abstract][Full Text] [Related]
6. Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1.
Dirksen RT; Avila G
Biophys J; 2004 Nov; 87(5):3193-204. PubMed ID: 15347586
[TBL] [Abstract][Full Text] [Related]
7. Ca2+-dependent excitation-contraction coupling triggered by the heterologous cardiac/brain DHPR beta2a-subunit in skeletal myotubes.
Sheridan DC; Carbonneau L; Ahern CA; Nataraj P; Coronado R
Biophys J; 2003 Dec; 85(6):3739-57. PubMed ID: 14645065
[TBL] [Abstract][Full Text] [Related]
8. Altered excitation-contraction coupling with skeletal muscle specific FKBP12 deficiency.
Tang W; Ingalls CP; Durham WJ; Snider J; Reid MB; Wu G; Matzuk MM; Hamilton SL
FASEB J; 2004 Oct; 18(13):1597-9. PubMed ID: 15289441
[TBL] [Abstract][Full Text] [Related]
9. Divergent functional properties of ryanodine receptor types 1 and 3 expressed in a myogenic cell line.
Fessenden JD; Wang Y; Moore RA; Chen SR; Allen PD; Pessah IN
Biophys J; 2000 Nov; 79(5):2509-25. PubMed ID: 11053126
[TBL] [Abstract][Full Text] [Related]
10. Ca2+ activation of RyR1 is not necessary for the initiation of skeletal-type excitation-contraction coupling.
O'Brien JJ; Feng W; Allen PD; Chen SR; Pessah IN; Beam KG
Biophys J; 2002 May; 82(5):2428-35. PubMed ID: 11964231
[TBL] [Abstract][Full Text] [Related]
11. Calmodulin binding to the 3614-3643 region of RyR1 is not essential for excitation-contraction coupling in skeletal myotubes.
O'Connell KM; Yamaguchi N; Meissner G; Dirksen RT
J Gen Physiol; 2002 Sep; 120(3):337-47. PubMed ID: 12198090
[TBL] [Abstract][Full Text] [Related]
12. Triadin binding to the C-terminal luminal loop of the ryanodine receptor is important for skeletal muscle excitation contraction coupling.
Goonasekera SA; Beard NA; Groom L; Kimura T; Lyfenko AD; Rosenfeld A; Marty I; Dulhunty AF; Dirksen RT
J Gen Physiol; 2007 Oct; 130(4):365-78. PubMed ID: 17846166
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin and FK506 reduce skeletal muscle voltage sensor expression and function.
Avila G; Dirksen RT
Cell Calcium; 2005 Jul; 38(1):35-44. PubMed ID: 15955561
[TBL] [Abstract][Full Text] [Related]
14. Ryanodine modification of RyR1 retrogradely affects L-type Ca(2+) channel gating in skeletal muscle.
Bannister RA; Beam KG
J Muscle Res Cell Motil; 2009; 30(5-6):217-23. PubMed ID: 19802526
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of the skeletal muscle ryanodine receptor ion channel-FKBP12 complex by the 1,4-benzothiazepine derivative S107.
Mei Y; Xu L; Kramer HF; Tomberlin GH; Townsend C; Meissner G
PLoS One; 2013; 8(1):e54208. PubMed ID: 23349825
[TBL] [Abstract][Full Text] [Related]
16. Reduced gain of excitation-contraction coupling in triadin-null myotubes is mediated by the disruption of FKBP12/RyR1 interaction.
Eltit JM; Szpyt J; Li H; Allen PD; Perez CF
Cell Calcium; 2011 Feb; 49(2):128-35. PubMed ID: 21310482
[TBL] [Abstract][Full Text] [Related]
17. Calcitonin gene-related peptide restores disrupted excitation-contraction coupling in myotubes expressing central core disease mutations in RyR1.
Vega AV; Ramos-Mondragón R; Calderón-Rivera A; Zarain-Herzberg A; Avila G
J Physiol; 2011 Oct; 589(Pt 19):4649-69. PubMed ID: 21825032
[TBL] [Abstract][Full Text] [Related]
18. Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling.
Yang T; Ta TA; Pessah IN; Allen PD
J Biol Chem; 2003 Jul; 278(28):25722-30. PubMed ID: 12732639
[TBL] [Abstract][Full Text] [Related]
19. FKBP12 modulates gating of the ryanodine receptor/calcium release channel.
Ondrias K; Marx SO; Gaburjakova M; Marks AR
Ann N Y Acad Sci; 1998 Sep; 853():149-56. PubMed ID: 10603943
[TBL] [Abstract][Full Text] [Related]
20. FKBP12 modulation of the binding of the skeletal ryanodine receptor onto the II-III loop of the dihydropyridine receptor.
O'Reilly FM; Robert M; Jona I; Szegedi C; Albrieux M; Geib S; De Waard M; Villaz M; Ronjat M
Biophys J; 2002 Jan; 82(1 Pt 1):145-55. PubMed ID: 11751303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
